Eosinophilic Fasciitis: Current and Remaining Challenges

Int J Mol Sci. 2023 Jan 19;24(3):1982. doi: 10.3390/ijms24031982.

Abstract

Eosinophilic fasciitis (EF), defined as diffuse fasciitis with eosinophilia by Shulman in 1974, is a disease with unknown etiology and whose pathogenesis is still being researched. The diagnosis is based on the clinical aspects (skin induration with an "orange peel" appearance), the lab results (eosinophilia, increased inflammatory markers), the skin biopsy with the pathognomonic histopathological result, as well as the typical MRI changes. The treatment includes glucocorticoids and immunosuppressive drugs. Due to severe refractory cases, the treatment remains a challenge. EF is still a disease with potential for further research.

Keywords: Shulman; eosinophilic fasciitis; systemic sclerosis.

Publication types

  • Review

MeSH terms

  • Eosinophilia* / diagnosis
  • Eosinophilia* / pathology
  • Fasciitis* / diagnosis
  • Fasciitis* / drug therapy
  • Fasciitis* / pathology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Skin / pathology

Substances

  • Immunosuppressive Agents

Supplementary concepts

  • Eosinophilic Fasciitis

Grants and funding

“Carol Davila” University of Medicine, Bucharest, Romania.